Table 1.
Total beam-on time (BOT), mean liver dose (MLD) and proportion of circulating lymphocytes receiving ≥0.5Gy (CL0.5) by treatment modality, beam energy and dose rate as a mean for all intrahepatic locations
| 1. Treatment modalities and mean MLD and CL0.5 of all locations | |||||||
|---|---|---|---|---|---|---|---|
| Treatment modality | Beam energy | Flattening filter | Dose rate (MU/min) | Fields / Arcs | Total BOT | MLD | CL0.5 |
| 3DCRT | 10 MV | FFF | 2400 | 7 | 57 s | 4.3 Gy | 15.9% |
| 3DCRT | 6 MV | FFF | 1400 | 7 | 111 s | 4.3 Gy | 23.6% |
| 3DCRT | 6 MV | FF | 600 | 7 | 253 s | 4.3 Gy | 30.9% |
| VMAT | 10 MV | FFF | 2400 | 2 | 74 s | 3.6 Gy | 19.0% |
| VMAT | 6 MV | FFF | 1400 | 3 | 147 s | 3.6 Gy | 23.6% |
| VMAT | 6 MV | FF | 600 | 4 | 363 s | 3.6 Gy | 25.1% |